ALN-APOC3 in Adult Participants With Dyslipidemia
Clinical trial NCT06784349 · COMPLETED
Trial details
- NCT number
- NCT06784349
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-27
- Primary completion
- 2026-02-25
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.